TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34182552

Group type: EXPERIMENTAL
Intervention: ICBT
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: IIPT
Number of subjects: 170

Group type: COMPARATOR
Intervention: Wait-list
Number of subjects: 170
Study: 36065092

Group type: EXPERIMENTAL
Intervention: ZYIL1 (oral NLRP3 inflammasome inhibitor)
Number of subjects: 48
Study: 35010722

Group type: EXPERIMENTAL
Intervention: Experimental group (conditioning activity)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (no conditioning activity)
Number of subjects: 11
Study: 32706442

Group type: EXPERIMENTAL
Intervention: Eccentric hamstring training at long-muscle length
Number of subjects: 40
Study: 34013673

Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sham therapy (control)
Number of subjects: 88
Study: 33764850

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36135055

Group type: EXPERIMENTAL
Intervention: Oncokompas (eHealth application)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Care as usual (waiting-list control group)
Number of subjects: 138
Study: 33831250

Group type: EXPERIMENTAL
Intervention: Piperacillin–tazobactam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 0
Study: 32735426

Group type: EXPERIMENTAL
Intervention: 3-minute rest interval (RI-3)
Number of subjects: 21

Group type: COMPARATOR
Intervention: 1-minute rest interval (RI-1)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (15 minutes rest)
Number of subjects: 21
Study: 34220712

Group type: EXPERIMENTAL
Intervention: Ding-Kun Pill (DKP) 7g twice daily
Number of subjects: 462

Group type: COMPARATOR
Intervention: Placebo 7g twice daily
Number of subjects: 462
Study: 32331028

Group type: EXPERIMENTAL
Intervention: Test group (viewed a video of a scripted interview with a standardized patient actor depicting TD movements)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Control group (viewed the same actors but without TD movements)
Number of subjects: 800
Study: 33449096

Group type: EXPERIMENTAL
Intervention: MRI-guided biopsy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Surgical pathology
Number of subjects: 20
Study: 32216911

Group type: COMPARATOR
Intervention: Continuation of neurohumoral blocker therapy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Withdrawal of renin‐angiotensin‐aldosterone system inhibitors
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Withdrawal of beta‐blockers
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Withdrawal of renin‐angiotensin‐aldosterone system inhibitors and beta‐blockers
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 80
Study: 33402419

Group type: EXPERIMENTAL
Intervention: erenumab 140 mg
Number of subjects: 246
Study: 32197732

Group type: EXPERIMENTAL
Intervention: DIBSS-C abdominal score
Number of subjects: 0
Study: 35751480

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A injection combined with finasteride and minoxidil
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control side (no botulinum toxin A injection)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A combined with finasteride and minoxidil
Number of subjects: 37
Study: 32531982

Group type: EXPERIMENTAL
Intervention: Prebiotic oligofructose-enriched inulin (10 g per day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 34
Study: 35889769

Group type: EXPERIMENTAL
Intervention: Nutraceutical combination containing phytosterols, bergamot, olive fruits, and vitamin K2
Number of subjects: 118
Study: 34034775

Group type: EXPERIMENTAL
Intervention: Passive leg raising (PLR) during CPR
Number of subjects: 588

Group type: COMPARATOR
Intervention: Control group (flat position during CPR)
Number of subjects: 588
Study: 33998356

Group type: EXPERIMENTAL
Intervention: Mastoscopic surgery
Number of subjects: 42

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 42
Study: 34081723

Group type: EXPERIMENTAL
Intervention: Pregnant women
Number of subjects: 61

Group type: COMPARATOR
Intervention: Non-pregnant women
Number of subjects: 61
Study: 32877886

Group type: EXPERIMENTAL
Intervention: NMES + PMT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: IMT + PMT
Number of subjects: 60

Group type: COMPARATOR
Intervention: PMT
Number of subjects: 60
Study: 36240610

Group type: EXPERIMENTAL
Intervention: Very low fixed dose of GH (0.1 mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard dose of GH (initially 0.13 mg/day, increased to 0.31 mg/day)
Number of subjects: 18
Study: 33377924

Group type: EXPERIMENTAL
Intervention: Individualized hemodynamic management using pleth variability index (PVI) aiming for PVI under 13%
Number of subjects: 438

Group type: COMPARATOR
Intervention: Standard management strategy maintaining mean arterial pressure above 65 mmHg
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Individualized hemodynamic management using pleth variability index (PVI)
Number of subjects: 438
Study: 36222197

Group type: EXPERIMENTAL
Intervention: Task-oriented training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cyclic rotary training
Number of subjects: 50
Study: 32490551

Group type: EXPERIMENTAL
Intervention: cilofexor 100 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: cilofexor 30 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 100
Study: 35505681

Group type: EXPERIMENTAL
Intervention: CPT, trunk-targeted PNF, and bihemispheric motor cortex stimulation with tDCS
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: CPT, trunk-targeted PNF, and sham tDCS
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional physical therapy (CPT) alone
Number of subjects: 54
Study: 34275488

Group type: EXPERIMENTAL
Intervention: Discontinuation of DMARDs
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided synovial biopsy
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Blood sampling and clinical evaluation
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Synovial biopsies
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Examination of blood, urine, and synovium
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Multivariate statistical techniques
Number of subjects: 118
Study: 34951717

Group type: EXPERIMENTAL
Intervention: Higher oxygenation target (PaO2 of 12 kPa)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Lower oxygenation target (PaO2 of 8 kPa)
Number of subjects: 780
Study: 33509921

Group type: EXPERIMENTAL
Intervention: Intra-arterial rtPA
Number of subjects: 984

Group type: COMPARATOR
Intervention: No intra-arterial rtPA
Number of subjects: 984
Study: 32007346

Group type: EXPERIMENTAL
Intervention: Targeted cognitive training (TCT) for 40 hours
Number of subjects: 44

Group type: COMPARATOR
Intervention: Active control condition (CG)
Number of subjects: 44
Study: 35162813

Group type: EXPERIMENTAL
Intervention: Short-term psychoanalytic psychotherapy (STPP) with transference work
Number of subjects: 69

Group type: COMPARATOR
Intervention: Short-term psychoanalytic psychotherapy (STPP) without transference work
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both STPP groups (with and without transference work)
Number of subjects: 69
Study: 32974999

Group type: EXPERIMENTAL
Intervention: Eriksson's theory of caritative caring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intercultural caring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caring for patients suffering from addiction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aesthetic surroundings in nursing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leadership and education for nursing teachers
Number of subjects: 0
Study: 36413383

Group type: EXPERIMENTAL
Intervention: bamlanivimab/etesevimab
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: sotrovimab
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: casirivimab/imdevimab
Number of subjects: 319
Study: 32078058

Group type: EXPERIMENTAL
Intervention: Voice rehabilitation (n=32)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No voice rehabilitation (n=34)
Number of subjects: 66
Study: 33469728

Group type: EXPERIMENTAL
Intervention: Intravenous GGS (freeze‐dried sulfonated human normal immunoglobulin)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intravenous methylprednisolone (steroid pulse)
Number of subjects: 32
Study: 32400000

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Everolimus + EDT (Leuprolide + Letrozole)
Number of subjects: 28
Study: 616316807

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 405

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 405
Study: 35450742

Group type: EXPERIMENTAL
Intervention: mirabegron 50 mg once daily
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: solifenacin 5 mg per day
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: combined solifenacin 5 mg and mirabegron 50 mg once daily
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 102
Study: 34919620

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate mouthwash
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32872748

Group type: EXPERIMENTAL
Intervention: Gout patients receiving anti-gout medication
Number of subjects: 179930

Group type: COMPARATOR
Intervention: Matched controls (no gout)
Number of subjects: 179930
Study: 32571250

Group type: EXPERIMENTAL
Intervention: LCES (Lhasa Childhood Eye Study)
Number of subjects: 1856
Study: 35050397

Group type: EXPERIMENTAL
Intervention: Cough Training (CT)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 53
Study: 34080258

Group type: EXPERIMENTAL
Intervention: Nuts containing low-calorie diet (NELCD)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Nut-free energy-restricted diet (NFLCD)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Both groups (NELCD and NFLCD)
Number of subjects: 67
Study: 32267624

Group type: EXPERIMENTAL
Intervention: Laparoscopic sacrohysteropexy (LSH)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Sacrospinous hysteropexy (SSHP)
Number of subjects: 126
Study: 33855908

Group type: EXPERIMENTAL
Intervention: TAS-guided IUD insertion
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: USSA
Number of subjects: 88
Study: 34354153

Group type: EXPERIMENTAL
Intervention: Dietary Arg:Lys ratio of 105% Arg relative to 10% higher Lys than NRC recommendations
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Dietary Arg:Lys ratio of 95% Arg relative to 10% higher Lys than NRC recommendations
Number of subjects: 576

Group type: COMPARATOR
Intervention: Dietary Lys content at NRC recommendation
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Dietary Lys content at 10% higher than NRC recommendation
Number of subjects: 576
Study: 33125399

Group type: EXPERIMENTAL
Intervention: Specifically composed music (Treated Group, TG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Familiar music (Placebo Group, PG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No music (Control Group, CG)
Number of subjects: 0
Study: 34739002

Group type: EXPERIMENTAL
Intervention: Early metabolic support (EMS) with peripheral amino acid infusions
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard of care (enteral nutrition as soon as feasible)
Number of subjects: 42
Study: 33822055

Group type: EXPERIMENTAL
Intervention: Routine health information system
Number of subjects: 5795

Group type: EXPERIMENTAL
Intervention: Quality assessment of health records
Number of subjects: 5795

Group type: EXPERIMENTAL
Intervention: Existing routine health information systems
Number of subjects: 5795
Study: 35102518

Group type: EXPERIMENTAL
Intervention: Portion-control plate with visual stimuli
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional plate
Number of subjects: 76
Study: 34425228

Group type: EXPERIMENTAL
Intervention: Gut microbiota (specifically Methanobacteriaceae family, Desulfovibrionales order, Ruminiclostridium5 genus)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suggestive microbial taxa identified under nominal significance (P < 0.05)
Number of subjects: 0
Study: 34059363

Group type: EXPERIMENTAL
Intervention: Original MethOd at pharmacy To ENhAnce Support for Health Improvement (OMOTENASHI)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional medication counselling method (CMC)
Number of subjects: 71
Study: 34839248

Group type: EXPERIMENTAL
Intervention: Bupivacaine‐Hydrochloride 0.5%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sodium‐Chloride 0.9% (placebo)
Number of subjects: 60
Study: 36385632

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - trained crossing 50 suddenly-appearing virtual obstacles.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control Group (CG) - merely walked on a treadmill.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - trained with VR adaptation.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Physical obstacle avoidance at T1 and T2.
Number of subjects: 32
Study: 32299097

Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone mineral combined with enamel matrix derivative (test)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Deproteinized bovine bone mineral alone (control)
Number of subjects: 8
Study: 33933825

Group type: EXPERIMENTAL
Intervention: Breathing Training (BT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 96
Study: 33107439

Group type: EXPERIMENTAL
Intervention: Block and Replace (BR)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Dose Titration (DT)
Number of subjects: 82
Study: 35793609

Group type: EXPERIMENTAL
Intervention: Na2SeO3 (sodium selenite) continuous infusion at a pharmacological dose of 4 mg Se/day on day-1, followed by a high nutritional dose of 1 mg Se/day for 9 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33577767

Group type: EXPERIMENTAL
Intervention: aQIV
Number of subjects: 6761

Group type: COMPARATOR
Intervention: Comparator vaccine
Number of subjects: 6761
Study: 32103326

Group type: EXPERIMENTAL
Intervention: Decontamination with polymyxin B, tobramycin, vancomycin, and amphotericin B, administered four times per day starting the day before surgery until postoperative day 7.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (amphotericin B only), administered four times per day starting the day before surgery until postoperative day 7.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Decontamination with polymyxin B, tobramycin, vancomycin, and amphotericin B.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (amphotericin B only).
Number of subjects: 80
Study: 35776749

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calendar-matched analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pre-specified trial analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Covariate adjustment methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data augmentation approach
Number of subjects: 0
Study: 32813949

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon
Number of subjects: 330

Group type: COMPARATOR
Intervention: Standard balloon
Number of subjects: 330
Study: 33129455

Group type: EXPERIMENTAL
Intervention: High concentration of toxic K. brevis (> 1 million cells L‐1) at normoxic levels (7.2 mg L‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate hypoxia (1.5 mg L‐1) with high concentration of K. brevis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Severe hypoxia (0.63 mg L‐1) with high concentration of K. brevis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normoxic control (7.3 mg L‐1) with no K. brevis
Number of subjects: 0
Study: 34641750

Group type: EXPERIMENTAL
Intervention: Mothers with asthma
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Mothers with asthma (asthma control levels)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Mothers without asthma
Number of subjects: 236
Study: 33428652

Group type: EXPERIMENTAL
Intervention: Patients with psychotic disorders
Number of subjects: 300

Group type: COMPARATOR
Intervention: Age
Number of subjects: 300

Group type: COMPARATOR
Intervention: Presence of a psychotic disorder
Number of subjects: 300

Group type: COMPARATOR
Intervention: Female gender
Number of subjects: 300

Group type: COMPARATOR
Intervention: Never married status
Number of subjects: 300

Group type: COMPARATOR
Intervention: Widowed/separated/divorced status
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Olanzapine treatment
Number of subjects: 300
Study: 34130445

Group type: EXPERIMENTAL
Intervention: INSIGHT algorithm (adjusted by 1 unit/day)
Number of subjects: 129

Group type: COMPARATOR
Intervention: EDITION algorithm (adjusted by 3 units/week)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: INSIGHT algorithm
Number of subjects: 129

Group type: COMPARATOR
Intervention: EDITION algorithm
Number of subjects: 129
Study: 33069888

Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 plus carboplatin (AUC 5 mg/mL/min) with pembrolizumab 200 mg (up to 2 years)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Pemetrexed 500 mg/m2 plus carboplatin (AUC 5 mg/mL/min) without pembrolizumab (chemotherapy alone)
Number of subjects: 123
Study: 32978116

Group type: EXPERIMENTAL
Intervention: Epley maneuver + betahistine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Epley maneuver only
Number of subjects: 100
Study: 34034784

Group type: EXPERIMENTAL
Intervention: COVID-19 specific monoclonal antibodies (mABs) authorized by the EUAs (bamlanivimab and etesevimab; casirivimab and imdevimab)
Number of subjects: 0
Study: 32162808

Group type: EXPERIMENTAL
Intervention: Sequential FOLFIRI followed by Cisplatin and Docetaxel
Number of subjects: 256

Group type: COMPARATOR
Intervention: 5-FU/LV
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: High inflammatory reaction
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Tumor PD-L1 ≥ 1% in sequential chemotherapy
Number of subjects: 256

Group type: COMPARATOR
Intervention: Tumor PD-L1 <1%
Number of subjects: 256
Study: 35627351

Group type: EXPERIMENTAL
Intervention: Core strength training (CST) programme (n = 16) performed thrice weekly
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (n = 13) performing only sport-specific karate training
Number of subjects: 29
Study: 33057670

Group type: EXPERIMENTAL
Intervention: treatment as usual with adjunctive psycho-social intervention for medication adherence
Number of subjects: 167

Group type: COMPARATOR
Intervention: treatment as usual without adjunctive psycho-social intervention
Number of subjects: 167
Study: 36167579

Group type: EXPERIMENTAL
Intervention: Electroacupuncture plus mindfulness meditation
Number of subjects: 165

Group type: COMPARATOR
Intervention: Sham electroacupuncture plus mindfulness meditation
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Electroacupuncture only
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 165
Study: 32459738

Group type: EXPERIMENTAL
Intervention: 13-week exercise-based intervention group (n = 33)
Number of subjects: 64
Study: 36172635

Group type: EXPERIMENTAL
Intervention: Big bubble deep anterior lamellar keratoplasty (BB-DALK)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Manual dissection due to failed BB technique
Number of subjects: 25
Study: 35776949

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fingerstick meter
Number of subjects: 10
Study: 32756839

Group type: EXPERIMENTAL
Intervention: Seeding rate of 311,000 plants ha‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Seeding rate of 360,000 plants ha‐1 (fixed population)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Seeding rate of 422,000 plants ha‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Decision strategy of increasing 20% seed population in lower ECa zones and decreasing 20% in higher ECa zones
Number of subjects: 6
Study: 35570106

Group type: EXPERIMENTAL
Intervention: Esophagogastrostomy with circular stapler (CS)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Double flap (DF) reconstruction
Number of subjects: 76

Group type: COMPARATOR
Intervention: Double tract (DT) reconstruction
Number of subjects: 76
Study: 32978675

Group type: EXPERIMENTAL
Intervention: Microneedling and 5% retinoic acid
Number of subjects: 42

Group type: COMPARATOR
Intervention: 5% retinoic acid alone
Number of subjects: 42
Study: 32150017

Group type: EXPERIMENTAL
Intervention: Single-session treatment group (26 patients)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Weekly management group (27 patients)
Number of subjects: 53
Study: 35351871

Group type: EXPERIMENTAL
Intervention: Physical activity counselling intervention (introductory behavioural coaching session followed by eight weekly follow-up sessions)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Physical activity counselling intervention
Number of subjects: 14
Study: 34633323

Group type: EXPERIMENTAL
Intervention: VR condition
Number of subjects: 114

Group type: COMPARATOR
Intervention: Non-VR (control) condition
Number of subjects: 114
Study: 34905661

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (3 Hz)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (1 Hz)
Number of subjects: 45

Group type: COMPARATOR
Intervention: SHAM stimulation
Number of subjects: 45
Study: 33971485

Group type: EXPERIMENTAL
Intervention: Mind-body activity program
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: ActiGraph wear reminders
Number of subjects: 13
Study: 35685611

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol and remifentanil
Number of subjects: 77
Study: 34343108

Group type: EXPERIMENTAL
Intervention: Metformin (1000–2000 mg daily for 3 months)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Insulin (non-MET group)
Number of subjects: 65
Study: 33433509

Group type: EXPERIMENTAL
Intervention: 0.1% curcumin mouthwash
Number of subjects: 74

Group type: COMPARATOR
Intervention: 0.15% benzydamine mouthwash
Number of subjects: 74